Improving the outcome for older women with breast cancer

British Journal of Surgery

Volumn 91, Issue 6, 2004, Pages 655-656

  Fentiman, I S ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; TAMOXIFEN;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LIFE EXPECTANCY; MAMMOGRAPHY; MASTECTOMY; PRIORITY JOURNAL; RISK ASSESSMENT; SHORT SURVEY; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; EARLY DIAGNOSIS; FEMALE; HUMANS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; TAMOXIFEN;

EID: 2942520945     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4619     Document Type: Short Survey

References (10)

1. Fennessy M, Bates T, Macrae K, Riley D, Houghton J, Baum T. Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer. Br J Surg 2004; in this issue.
2. Mustacchi G, Ceccherini R, Milani S, Pluchinotta A, De Matteis A, Maiorino L et al. Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial. Ann Oncol 2003; 14: 414-420.
3. Gazet J-C, Ford HT, Coombes RC, Bland JM, Sutcliffe R, Quilliam J. Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer. Eur J Surg Oncol 1994; 20: 207-214.
4. Kenny FS, Robertson JFR, Ellis IO, Elston CW, Blamey RW. Long-term follow-up of elderly patients randomised to primary tamoxifen or wedge mastectomy as initial therapy for operable breast cancer. Breast 1998; 7: 335-339.
5. Fentiman IS, Christiaens M-R, Paridaens R, van Geel A, Rutgers E, Berner J et al. Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10 851 comparing tamoxifen alone with modified radical mastectomy. Eur J Cancer 2003; 39: 309-316.
6. Fentiman IS, van Zyl J, Karydas I, Chaudary MA, Margreiter R, Legrand C et al. Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10 850 comparing modified radical mastectomy with tumourectomy plus tamoxifen. Eur J Cancer 2003; 39: 300-308.
7. Baum M, Budzar AU, Cuzick J, Forbes J, Houghton JH, Klijn JG et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 2002; 359: 2131-2139.
8. Goss PE, Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ et al. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 2003; 349: 1793-1802.
9. Polgar C, Sulyok Z, Fodor J, Orosz Z, Major T, Takacsi-Nagy Z et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol 2002; 80: 121-128.
10. Veronesi U, Gatti G, Luini A, Intra M, Ciocca M, Sanchez M et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. Arch Surg 2003; 138: 1253-1256.